
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Name | Symbol | Market | Type |
---|---|---|---|
Global X Genomics and Biotechnology | NASDAQ:GNOM | NASDAQ | Exchange Traded Fund |
Price Change | % Change | Price | Bid Price | Offer Price | |
---|---|---|---|---|---|
0.135 | 1.55% | 8.82 | 8.70 | 9.00 |
High Price | Low Price | Open Price | Traded | Last Trade |
---|---|---|---|---|
8.875 | 8.68 | 8.70 | 35,276 | 20:00:02 |
Date | Price | Price Change | Price % Change | Low Price | High Price | Traded |
---|---|---|---|---|---|---|
18 Mar 2025 | 8.685 | -0.29 | -3.26% | 8.67 | 8.7765 | 46,881 |
17 Mar 2025 | 8.9779 | 0.14 | 1.60% | 8.80 | 9.04 | 91,236 |
14 Mar 2025 | 8.8369 | 0.10 | 1.11% | 8.80 | 8.90 | 25,811 |
13 Mar 2025 | 8.74 | -0.23 | -2.51% | 8.71 | 9.04 | 38,169 |
12 Mar 2025 | 8.965 | 0.16 | 1.82% | 8.83 | 9.00 | 34,117 |
11 Mar 2025 | 8.8046 | 0.03 | 0.39% | 8.59 | 8.885 | 71,093 |
10 Mar 2025 | 8.77 | -0.37 | -4.07% | 8.74 | 9.0479 | 72,746 |
07 Mar 2025 | 9.1419 | 0.08 | 0.84% | 8.94 | 9.19 | 45,970 |
06 Mar 2025 | 9.0656 | -0.04 | -0.49% | 8.98 | 9.131 | 59,885 |
05 Mar 2025 | 9.11 | 0.25 | 2.82% | 8.89 | 9.11 | 310,381 |
04 Mar 2025 | 8.86 | -0.02 | -0.23% | 8.64 | 8.9999 | 120,306 |
03 Mar 2025 | 8.88 | -0.35 | -3.79% | 8.84 | 9.1796 | 103,937 |
28 Feb 2025 | 9.23 | 0.07 | 0.77% | 9.04 | 9.23 | 74,824 |
27 Feb 2025 | 9.1593 | -0.27 | -2.87% | 9.15 | 9.49 | 35,155 |
26 Feb 2025 | 9.43 | 0.04 | 0.48% | 9.36 | 9.59 | 47,682 |
25 Feb 2025 | 9.385 | -0.30 | -3.05% | 9.29 | 9.635 | 108,433 |
24 Feb 2025 | 9.68 | -0.15 | -1.53% | 9.6331 | 9.82 | 110,824 |
21 Feb 2025 | 9.83 | -0.21 | -2.12% | 9.8167 | 10.18 | 91,983 |
20 Feb 2025 | 10.0432 | -0.13 | -1.25% | 10.02 | 10.18 | 131,111 |
19 Feb 2025 | 10.1703 | 0.16 | 1.55% | 9.98 | 10.21 | 95,003 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions